Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01694004 · ClinicalTrials.gov registry record · Phase 1
Nutrient Sensing in the Duodenum
A Phase 1 study of The Effect of LCFA on Nutrient Absorption, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 16
- Enrollment target
- 1
- Study location
NCT01694004: Completed Phase 1 study of The Effect of LCFA on Nutrient Absorption, sponsored by Vanderbilt University Medical Center.
NCT01694004 is a Phase 1 study of The Effect of LCFA on Nutrient Absorption that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 16 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01694004, a Phase 1 study of The Effect of LCFA on Nutrient Absorption, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 16 participants
- Enrollment target
- 1
- Study location
Study Summary
Preliminary studies in humans suggest that the presence of lipids in the gut can modify glucose absorption. The overall hypothesis of this proposal is that long chain fatty acid sensing in the duodenum has a significant role in modifying nutrient (glucose and amino acid) absorption from the GI tract through a gut-brain-gut axis.
Primary Outcome
Stable isotope tracers (glucose or amino acid) will be administered intravenously (IV) and intraduodenally (ID) and tracer rate of appearance in the plasma will be measured.
Conditions Studied
Interventions
- DRUG Benzocaine Infusion into Duodenum
Study Locations (1)
Tennessee
- Vanderbilt University Medical Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2012-11 |
| Est. Completion | 2014-10-27 |
| Phase | Phase 1 |
What the finished NCT01694004 record still lists
NCT01694004 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (73% lower).
The record links to 1 condition, with The Effect of LCFA on Nutrient Absorption appearing as the primary indexed condition, and to 1 intervention - of which Benzocaine Infusion into Duodenum is the first listed.
NCT01694004 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT01694004 about?
NCT01694004 is a clinical study titled "Nutrient Sensing in the Duodenum". Preliminary studies in humans suggest that the presence of lipids in the gut can modify glucose absorption. The overall hypothesis of this proposal is that long chain fatty acid sensing in the duodenum has a significant role in modifying nutrient (glucose and amino acid) absorption from the GI tract...
What is the current status of trial NCT01694004?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 16 participants. The study started on 2012-11. Estimated completion is 2014-10-27.
What conditions does trial NCT01694004 study?
This clinical trial studies the following conditions: The Effect of LCFA on Nutrient Absorption.
What interventions are being tested in trial NCT01694004?
The interventions under investigation include: Benzocaine Infusion into Duodenum (DRUG).
Who is sponsoring clinical trial NCT01694004?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01694004 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01694004's enrollment target sits among peer trials
16 1786th of 2000 higher than 203 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia